Sec. 401. Treatment of genetic variants and synthetic products of select agents and toxins
167 words·~1 min read·
/bill/118/s/2333/is/section-401·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 351A(a)(1) of the Public Health Service Act ( 42 U.S.C. 262a(a)(1) ) is amended by adding at the end the following: For purposes of the list under this paragraph, the following shall be considered to be a biological agent or toxin included on the list: Any biological agent that incorporates nucleic acids coding for a virulence factor from a listed agent or toxin. Any biological agent or toxin that is genetically homologous to a listed agent or toxin with respect to nucleotides coding for virulence factors or toxicity.
Any biological agent or toxin that is synthetically derived with virulence or toxicity characteristics of a listed agent or toxin. Any nucleic acid that encodes for components contributing to pathogenicity, transmissibility, or toxicity of a listed agent or toxin. The Secretary may exempt from inclusion on the list under this paragraph any biological agent, toxin, or nucleic acid described in clause (i), if such agent, toxin, or nucleic acid does not meet the criteria under subparagraph (B). .
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 401
Treatment of genetic variants and synthetic products of select agents and toxins
Cites 1Cited by 0 across 0 sources